The invention generally relates to biotechnology, and, more specifically, to the field of diagnostics, such as nucleic acid amplification on a surface.
Nucleic acid amplification in solution-based reactions, either through thermal cycling (e.g., polymerase chain reaction “PCR” and its modifications) or isothermal amplification (e.g., rolling circle amplification “RCA,” Ionian method, Invader) is well established and has been widely used for the last 25 years. There is, however, an intrinsic limitation in solution-based reactions with respect to multiplexing, due to multiple competitive processes, which introduce bias in quantitative features (concentrations) of multiple targets. Two approaches emerged to overcome these limitations: non-specific whole genome amplification through the use of short scrambled primers or amplifications based on generic oligoT primer (and its permutations) in conjunction with scrambled primers for messenger ribonucleic acid (“mRNA”) amplifications. In all cases, reaction products are interrogated through post-amplification techniques: arrayed capture probes, electrophoresis, or solution-based deoxyribonucleic acid (“DNA”) specific dyes (e.g., minor groove binders, major grove binders).
Recent advances in attempts to overcome competitive interactions of solution based amplification include separating amplifications in half reactions between solution reactions and interface-based (immobilized) reactions, where half of the primers are in solution, while the other half are immobilized in/on the interface (hydrogels, membranes of organic (nitrocellulose) or inorganic (Al203) origin). Although advantageous from point of view of separating reactions, there methods are marginally productive, since competition and different efficiencies of amplification still contribute to resulting quantitative biases.
Another approach has been to immobilize both sets of primers on a substrate. The primers are fixed on a substrate so that the primers are still in solution but immobilized in place. The primers are fixed on the substrate via linking compounds. Target DNA is introduced into the solution, denatured, and then allowed to bind with the immobilized primers. Amplification conditions are imposed on the solution to make copies of the target DNA. Denaturing condition are then imposed to separate the target DNA from the extended primers. The initial target DNA is then free to bind with a different set of primers and the process is repeated. Additionally, any primers that have been extended as copies of the target DNA are also able to bind with adjoining primers and also result in additional copies of the target DNA. The process is repeated numerous times until sufficient copies of the target DNA are created from the immobilized primers. Ideally, each cycle of the process results in a doubling of the target DNA that was present before the cycle started. If this ideal is met, then the amplification efficiency is said to equal 100%.
However, the above approach is problematic for target DNA that are 130 base pairs or less in length. DNA that is 130 base pairs or less in length is not very flexible. Instead, the DNA is rather rod-like and resists bending. Therefore, after a primer has been extended to form a copy of the target DNA it is difficult for the extended primer to bend and bind with an adjoining primer. That limits the copies that may be made from the extended primer. This lowers the amplification efficiency for the process and therefore increases the amount of time it takes to amplify the target DNA.
Another problem with the above approach is that often a high density of primers are immobilized on the substrate. This is done to try and increase the probability that when a primer has been extended, there is a complementary primer nearby to which the extended primer can bind. This is done in the hopes that on the next cycle, the nearby complementary primer can also be extended, and, thus, keep the amplification efficiency closer to 100%. A problem with having a high density of primers on the substrate is that if the primers are too close, then the primers tend to sterically hinder the movement of the adjacent primers. Thus, if the primer density is too high, then it is even more difficult for copied target DNA that is 130 base pairs or less in length to bend and bind with an adjoining complementary primer.
Another problem with the above approach is that often the concentration of enzyme, such as a heat stable polymerase, used to extend the primers is high. The enzyme concentration is elevated to increase the probability that if a target DNA does bind to a primer, then there is enzyme available to extend the primer to generate extension products of considerable length (up to several kilo base pairs). Enzyme concentrations up to micromolar concentrations are used. However, the higher the enzyme concentration, then the more likely it is that an error will be introduced into the copy of the target DNA (i.e., the copy will not be an exact duplicate of the complementary target DNA). If all of the copies are exact duplicates, then it is said that the fidelity is 100%. High enzyme concentration can be a problem when looking for the frequency with which mutations occur in a target nucleic acid. If the fidelity is low, then it is difficult to know whether the variation from the target DNA was due to mutation or copying error.
U.S. Pat. No. 5,641,658, filed Aug. 3, 1994, the contents of the entirety of which are incorporated by this reference, discloses a method for performing amplification of a nucleic acid with primers bound to a solid support.
There is a need for methods and devices for amplifying target DNA having 130 base pairs or less.
Certain embodiments of the invention include a method of building a surface amplification device. The method includes identifying a first primer having an ability to bind to a sense strand of the target nucleic acid. The method also includes identifying a second primer having an ability to bind to an antisense strand of the target nucleic acid. The first primer and the second primer may be connected via a connecting oligonucleotide. The first primer may be attached to a substrate via a first flexible linking compound. The second primer may also be attached to the substrate via a second flexible linking compound. Then, the connecting oligonucleotide may be removed to disconnect the first primer from the second primer. The first primer may be immobilized on the substrate via the first flexible linking compound. The second primer may be immobilized on the substrate via the second flexible linking compound.
Other embodiments of the invention may include a method of amplifying a target nucleic acid. The method may include immobilizing first primers and second primers on a substrate via flexible linking compounds. The flexible linking compounds may be of sufficient length, rotability, and flexibility so that the flexible linking compounds tend to bend and rotate rather than any extension products that may eventually bind to an unextended primer. A sample may be introduced potentially containing the target nucleic acids to the first primers and the second primers. Denaturing conditions may be imposed to separate any target nucleic acids present in the sample into separate target sense strands and target antisense strands. Hybridization conditions may be imposed to anneal any target sense strands and first primers and to anneal any target antisense strands and second primers. Amplification conditions may be imposed to extend any annealed first primers and any annealed second primers. Denaturing conditions may be imposed to separate any target sense strands from any extension products of the first primers and any target antisense strands from any extension products of the second primers. Hybridization conditions may be imposed to anneal any extension products of the first primers with unextended second primers and to anneal any extension products of the second primers with unextended first primers. Amplification conditions may be imposed to extend the unextended second primers and the unextended first primers.
Additional embodiments include a target nucleic acid amplification device. The device may include a substrate. A first primer and a second primer may be attached to the substrate via flexible linking compounds. The flexible linking compounds may be of sufficient length, rotability, and flexibility so that the flexible linking compounds tend to bend and rotate rather than any extension products that may eventually bind to unextended primers.
Embodiments of the invention include methods of building a target nucleic acid surface amplification device as well as the device itself. Embodiments of the invention include methods of amplifying a target nucleic acid.
In one method of building a target nucleic acid surface amplification device, first the target nucleic acid may be identified. Examples of target nucleic acids include DNA or ribonucleic acids (“RNA”). The target nucleic acid may be 130 base pairs in length or less. The target nucleic acid may also be 50 base pairs in length or less. In one embodiment, the target nucleic acid is between 25 and 100 base pairs in length. Generally, the target nucleic acids are double-stranded. Or in other words, each target nucleic acid has a target “sense” strand and a target “antisense” strand. The target antisense strand is complementary and antiparallel to the target sense strand. For example, with the double helix of DNA, one side of the helix is the sense strand and the other side of the helix is the antisense strand. Each target sense strand and target antisense strand has what is referred to as a 5′ end and a 3′ end. The 5′ end of the target sense strand is complementary to the 3′ end of the target antisense strand (assuming the target sense strand is no longer than the target antisense strand). When RNA is the target nucleic acid it may be necessary to first reverse transcribe the RNA to form complementary DNA (“cDNA”) having a target sense strand and a target antisense strand.
Once the target nucleic acid is identified, then primers may be identified that are able to bind to the target nucleic acid. A first primer may be identified that is able to bind to a region of the target sense strand. A second primer may be identified that is able to bind to a region of the target antisense strand. Eventually, the first primer will be extended to form complementary copies of the target sense strand (i.e., duplicate copy of the antisense strand). The first primer and second primer may bind to any region of the respective target sense and antisense strand. However, only the regions downstream from the primers may be copied. Therefore, for example, if the first primer binds to the middle of the target sense strand, then only half of the target sense strand may be copied. It should be understood that the terms “first primer” and “second primer” are not intended to place a greater importance or priority in time to the “first primer,” but rather, the terms are used to differentiate between the two types of primers. Binding may occur by the formation of hydrogen bonds between the nucleotides of the primer and the nucleotides of the sense or antisense strand (i.e., hybridization). First and second primers may be between 15 and 25 nucleotides in length. In one embodiment, the first primers and second primers are 20 to 22 nucleotides in length. However, there is no limitation on the length of the first and second primers.
Identifying the first and second primers may include searching a database, conducting tests on the target nucleic acid, or any method known in the art or later developed for identifying primers. The first and second primers may be prepared using peptide synthesis or by any other method known in the art or later developed.
Once the first and second primers are identified and prepared, then a connecting compound may be identified that has the ability to connect a single first primer to a single second primer. The connecting compound may be able to bind to at least a portion of the first primer while also binding to at least a portion of the second primer.
The length of the connecting compound may be used to set the distance between the first primer and the second primer during the immobilization of the first and second primers. Therefore, it may be desirable to optimize the length of the connecting compound. In one embodiment, the connecting compound may equal the length of the first primer, plus the length of the second primer, plus the length of an additional 1 to 10 nucleotides (i.e., about 3.4 Å to about 34 Å). This may be desirable when the connecting compound binds along the full length of both the first primer and the second primer and when the desired additional length of the extension product is between 1 to 10 nucleotides.
The connecting compound may be a synthetic oligonucleotide. Any method of synthetically creating oligonucleotides known in the art or later developed may be used. In one embodiment, automated oligonucleotide synthesis using phosphoamidite chemistry with a variety of protecting groups (DMT, Fmoc, etc.) Once the connecting compounds are prepared, then they may be connected to the first and second primers to form a primer pair.
Reference will now be made to the figures, wherein like numerals refer to like elements. It should be understood that the drawings are not necessarily to scale.
Either before or after connecting the first primers 32 and the second primers 34 via the connecting compounds 15, the first primers 32 and the second primers 34 may each be attached to a different flexible linking compound 20 as illustrated in
Flexible linking compounds 20 may be made from any material with sufficient flexibility and rotability. For examples, flexible linking compounds 20 may include polysaccharides, or organic linear polymers, such as polyethylene glycol (“PEG”), polyacrylamide, and uncross-linked derivatives. Flexible linking compounds 20 may be functionalized in order to achieve immobilization on the surface of substrate 10. Flexible linking compounds 20 may have features on the non-immobilized end for attachment to first primers 32 and second primers 34. Attachment between flexible linking compounds 20, first primers 32 or second primers 34, and substrate 10 may be accomplished by chemical or affinity attachment or by any other method known in the art or later developed.
Next, as illustrated in
It should be understood that numerous primer pairs 30 may be seeded onto substrate 10 via flexible linking compounds 20. The concentration of primer pairs 30 in solution may be controlled to determine the average density of primer pairs 30 on the surface of substrate 10. The correlation between primer pair 30 concentration in solution and the resulting average density of primer pairs 30 on the surface of substrate 10 may be determined experimentally. For example, a solution with a known concentration of labeled primer pairs 30 may be formed over substrate 10. The primer pairs 30 that attach to the surface of substrate 10 may then be detected and quantified. A correlation could then be established between primer pair 30 concentration in solution and average density on the surface of substrate 10. The average distance between primer pairs 30 could then be determined.
The density of primer pairs 30 on the surface of substrate 10 may be controlled to provide optimal distance between primer pairs 30. For example, adjacent primer pairs 30 may be placed close enough together so that an extension product 52 of an extended primer 32 (see
Regarding substrate 10, substrate 10 may be any substrate known in the art for immobilizing primers. For example, substrate 10 may be a bead, such as a latex bead, or a a flat surface, such as a glass or polymer surface. The substrate 10 may be made from a material that is compatible with, or may be made to be compatible with, flexible linking compounds 20. Substrate 10 may also be designed to enhance the detection of target nucleic acid amplification. Possible enhanced interfaces include: membranes, thin film planar waveguides, fiber optics guides, surface modifications with polymeric or inorganic porous beads, nanoparticles and nanocavities, and efficient selective excitation substrates (e.g., evanescent field).
After the flexible linking compounds 20 are attached to substrate 10, then connecting compounds 15 may be removed, as illustrated in
Surface amplification device 100 may also be used for detecting a frequency of mutations in a target nucleic acid, such as a single nucleotide polymorphism (“SNP”). For example, either first primer 32 and/or second primer 34 may be designed to be complementary to a potential mutation in the target nucleic acid. If the mutation is present in a sample containing the target nucleic acid, then the mutated target nucleic acid will be amplified. If the mutation is not present, then the target nucleic acid will not be amplified. Real-time detection and quantitative analysis may be used to determine the frequency at which the mutation occurs in the target nucleic acid.
It should be understood that surface amplification device 100 may be part of a larger device and/or system. For example, surface amplification device 100 may be part of a flow system where the surface of substrate 10 is periodically or continuously flushed. Surface amplification device 100 may be part of an immersion system where substrate 10 is immersed in a bath containing any necessary reagents in solution.
Surface amplification device 100 may be part of a microarray. In this embodiment, the surface of the microarray may be the surface of substrate 10. Spots may be formed on the surface of the microarray having first primers 32 and second primers 34 immobilized via flexible linking compounds 20. The necessary reagents and samples may be administered drop-wise to the individual spots. In one embodiment, each spot of the microarray may designed to amplify a different target nucleic acid. In another embodiment, all of the spots may be designed to amplify the same target nucleic acid.
Surface amplification device 100 may be incorporated into a self-contained reaction cartridge. The reaction cartridge may contains all of the necessary reagents needed to perform an assay. The reaction cartridge may have a port for introduction of the sample and separate isolated chambers for buffers, enzymes, and detection agents (e.g., dyes or labeled oligonudeotides). At programmed intervals, reagents may be released from the reagent chambers and delivered to a central reaction site, containing the sample (and possibly the target nucleic acids) and first primers 32 and second primers 34 immobilized on substrate 10 via flexible linking compounds 20.
In an alternative embodiment of building surface amplification device 100, flexible linking compounds 20 may be attached to the surface of substrate 10 prior to attaching primer pairs 30 to the flexible linking compounds 20. In this embodiment, the optimal density of flexible linking compounds 20 needed to mesh with the primer pairs 30 may be calculated. After the primer pairs 30 are attached to the flexible linking compounds 20, then the connecting compounds 15 may be removed.
In another alternative embodiment of building surface amplification device 100, connecting compounds 15 may not be used. Instead, flexible linking compounds 20 may be pre-seeded on the surface of substrate 10 with a desired density. First primers 32 and second primers 34 may be introduced into solution in equimolar quantities, without being paired together, and attached to the flexible linking compounds 20.
Turning now to other embodiments of the invention, embodiments of the invention include methods of amplifying a target nucleic acid. The methods of amplifying a target nucleic acid may also be used for detecting whether a target nucleic acid is present in a sample.
In one method of amplifying a target nucleic acid, first primers and second primers may be immobilized on a substrate via flexible linking compounds. The flexible linking compounds may be of sufficient length, rotability, and flexibility so that the flexible linking compounds tend to bend and rotate rather than any extension product of one primer that may eventually bind to another primer. The flexible linking compounds and the primers attached thereto may be optimally seeded to reduce steric hindrances between the first primers and second primers. They may also be optimally seeded to promote annealing between extension products of first or second primers and adjoining unextended first or second primers. The first primers and second primers may be immobilized according the embodiments heretofore discussed and/or illustrated in
Next, a sample potentially containing target nucleic acids may be introduced to the immobilized first primers and second primers.
After the sample is introduced to surface amplification device 100, then denaturing conditions may be imposed to separate any target nucleic acids 40 present in the sample into separate target sense strands 42 and target antisense strands 44. Denaturing conditions may be imposed by elevating the temperature, changing the ionic strength, and/or altering the pH of the solution. Any method known in the art, or later developed, for denaturing nucleic acids may be used.
After any target nucleic acids 40 are denatured, then hybridization conditions may be imposed to anneal any target sense strands 42 and first primers 32 and to anneal any target antisense strands 44 and second primers 34.
Next, amplification conditions may be imposed to extend any annealed first primers and any annealed second primers.
In one embodiment, the enzyme (e.g., thermal stable polymerase) that is used to extend first primers 32 and second primers 34 has a concentration that is lower than the concentration of target nucleic acids 40 present in the sample. The enzyme concentration may be low because embodiments of the present invention may have an increased amplification efficiency compared to surface amplifications without the benefit of embodiments of the present invention. Additionally, the shorter extension products 52 and 54 are, then the less enzyme needed. Thus, when extension products 52 and 54 are 130 base pairs or less, then the amount of enzyme needed may be reduced. The lower enzyme concentration may increase the fidelity of the amplification. In another embodiment, the concentration of enzyme used may be an order of magnitude less than the amount of enzyme commonly used with surface amplifications with immobilized primers. The increased fidelity of certain embodiments of the invention may make surface amplification device 100 useful in identifying mutations in target nucleic acids that have a low frequency of mutation.
After amplification, denaturing conditions may be imposed to separate any target sense strands 42 from any extension products 52 of first primers 32 and any target antisense strands 44 from any extension products 54 of second primers 34, such as illustrated in
Hybridization conditions may then be imposed, such as illustrated in
After hybridization, amplification conditions may be imposed to extend unextended second primer 34, such as illustrated in
The process of imposing denaturing conditions, imposing hybridization conditions, and imposing amplification conditions may be repeated a number of times until substantially all of the first primers 32 and the second primers 34 have been extended.
Methods of assaying target nucleic acids 40 may include monitoring substrate 10 to detect extension products 52 and 54. Detecting extension products 52 and 54 may indicate the presence of target nucleic acids 40 in the sample. A lack of detecting extension products 52 and 54 may indicate the absence of target nucleic acids 40 in the sample. A variety of detection systems may be used.
For example, fluorescence-based systems may be used. In one embodiment, fluorescence resonance energy transfer (“FRET”) may be used. In one possible use of FRET, the 3′ ends of each of the first primers 32 and second primers 34 are labeled with a fluorescent moiety. The first primers 32 may be labeled with a donor moiety and the second primers 34 labeled with an acceptor moiety, or vice versa. The donor moiety may be a fluorophore and the acceptor moiety may quench the frequency of light emitted by the donor moiety. In this embodiment, when an extension product 52 of a primer 32 binds to a primer 34, then the donor moiety may be sufficiently close to the acceptor moiety that, upon excitation of the donor moiety, FRET occurs and the intensity of emitted light is reduced. Additionally, U.S. Publication 2002/0197611, published Dec. 26, 2002, the contents of the entirety of which are incorporated by this reference, discloses methods of labeling primers. Thus, it is possible to detect when either a first primer 32 or second primer 34 has been extended. Thus, it is possible to detect whether target nucleic acids 40 are present in the sample.
Additionally, multiple target nucleic acids 40 may be amplified and detected. For example, a first set of first primers 32 and second primers 34 may be complementary to a first target nucleic acid. A second set of first primers 32 and second primers 34 may be complementary to a second target nucleic acid. The first set of primers may be labeled in a manner that is detectably distinguishable from the second set of primers (e.g., donor fluorophores that fluoresce at different wavelengths).
Other fluorescence-based systems may also be used. For example, the intercalating dyes would detectably fluoresce, upon excitation, if double-stranded nucleic acids were present in surface amplification device 100. However, intercalating dyes are generally non-specific. Therefore, it would be unclear based just on the fluorescence alone, whether it was extension product 52 and 54 binding together or some other nucleic acids.
Additionally, non-fluorescence-based systems may also be used for monitoring substrate 10. For example, if target nucleic acids 40 are present, then the amount of target nucleic acids 40 may be sufficiently increased to actually be a detectable amount of mass for use with tools such as mass spectrometers.
In addition to qualitative analysis, methods of assaying target nucleic acids 40 may include performing real-time quantitative analysis of target nucleic acids 40 based upon data collected during monitoring substrate 10.
As discussed above, embodiments of the present invention may have increased amplification efficiency, fidelity and reduced amplification time. Thus, embodiments of the present invention may make surface amplification much more feasible as a method of amplifying target nucleic acids.
The aforementioned methods and devices are not meant to be limiting. Other steps known in the art or developed in the future for amplifying specific types of target nucleic acids may also be added to the above methods and/or implemented with the above devices.
Specific embodiments have been shown by way of example in the drawings and have been described in detail herein. However, it should be understood that the invention is not intended to be limited to the particular forms disclosed. Rather, the invention is to cover all modifications, equivalents, additions, and alternatives falling within the spirit and scope of the invention as defined by the following appended claims.
This application is a continuation-in-part of U.S. patent application Ser. No. 11/633,981 filed on Dec. 4, 2006, which claims the benefit of the filing date of U.S. Provisional Patent Application 60/741,688 filed on Dec. 2, 2005, the contents of the entirety of both of which are incorporated by this reference.
Number | Date | Country | |
---|---|---|---|
60741688 | Dec 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11633981 | Dec 2006 | US |
Child | 11809726 | May 2007 | US |